SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: smh who wrote (3736)10/6/1999 9:17:00 AM
From: Biomaven  Read Replies (1) of 10280
 
This is kind of old news - basically Lehany was bringing her estimate of Xopenex sales into line with other analysts.

I'm encouraged by the trend in Xopenex script numbers, which should also climb as asthma season approaches. There are also reports of a deal with Innovex (a QTRN division) to detail the drug, although there's been no official confirmation.

Still no buzz on the asthma newsgroup about Xopenex - someone needs to learn a little guerilla marketing here - get a satisfied patient or two to post their experiences.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News